MetaCap

AN2 Therapeutics Statistics

NASDAQ: ANTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

5.08-0.14 (-2.68%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

AN2 Therapeutics by the numbers

AN2 Therapeutics has a market capitalization of $192.8 million based on 37.94M shares outstanding. With trailing EPS of $-0.91, AN2 Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 12.5% above its 50-day average and 17.7% above its 200-day average.

Average daily trading volume is 289.29K shares, or about $1.5 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ANTX valuation vs. peer median

ANTX compared with the median of 8 peer companies
MetricANTXPeer medianDifference
Market cap$192.75M$197.61M-2%
Avg. volume289.29K321.77K-10%

Peer median across 8 companies: ACIU, YARW, BIOA, RNAC, NGEN, DRUG, BCYC, FTH.

Valuation

Price and trading

Previous close
5.22
Open
5.13
Day range
4.99 – 5.49
52-week range
1.00 – 7.19
52-week change
+366.06%
Beta
—
Volume
332.67K

Dividends and events

Annual dividend
None
Next earnings date
Aug 14, 2025

Additional statistics

Market Cap
192.75M
Forward Pe
-6.64
Eps
-0.91
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
7.19
Week52 Low
1.00
Avg Volume
289.29K
Shares Outstanding
37.94M
Ma50
4.51
Ma200
4.32
Earnings Date
Aug 14, 2025
Pct From52w High
-29.35%
Pct From52w Low
408.00%

Related